Journal of Biological Chemistry · 2009 · 81 citations · 30 references
Life SciencesImmunologyMicrobiologyCell SignalingInflammationInnate ImmunityCytokine BiologyCytokine RegulationImmune Cell SignalingInflammatory ProcessesInflammatory SignalingMacrophage BiologyCytokine Gene Expression RegulationIntracellular Signaling PathwaysMacrophage Inflammatory ResponsesMacrophage Signaling PathwaysMyd88-dependent SignalingTh2 Immune ResponseToll-like Receptor-mediated Cytokine InductionToll-like Receptor-mediated Innate Immune Response
Gram-negative bacterial lipopolysaccharide (LPS) activates macrophages by interacting with Toll-like receptor 4 (TLR4) and triggers the production of various pro-inflammatory Th1 type (type 1) cytokines such as IFNγ, TNFα, and IL8. Though some recent studies cited macrophages as potential sources for Th2 type (type 2) cytokines, little however is known about the intracellular events that lead to LPS-induced type 2 cytokines in macrophages. To understand the mechanisms by which LPS induces type 2 cytokine gene expression, macrophages were stimulated with LPS, and the expression of IL-4 and IL-5 genes were examined. LPS, acting through TLR4, activates both type 1 and type 2 cytokine production both in vitro and in vivo by using macrophages from C3H/HeJ or C3H/HeOuJ mice. Although the baseline level of both TNFα and IL-4 protein was very low, TNFα was released rapidly after stimulation (within 4 h); however, IL-4 was released after 48 h LPS stimulation in secreted form. Silencing of myeloid differentiation protein (MyD88) and TRIF-related adaptor molecule (TRAM), using small interfering RNA abolished IL-4 induction induced by LPS whereas silencing of TRAM has no effect on TNFα induction, thereby indicating that LPS-induced TNFα is MyD88-dependent but IL-4 is required both MyD88 and TRAM. These findings suggest a novel function of LPS and the signaling pathways in the induction of IL-4 gene expression. Gram-negative bacterial lipopolysaccharide (LPS) activates macrophages by interacting with Toll-like receptor 4 (TLR4) and triggers the production of various pro-inflammatory Th1 type (type 1) cytokines such as IFNγ, TNFα, and IL8. Though some recent studies cited macrophages as potential sources for Th2 type (type 2) cytokines, little however is known about the intracellular events that lead to LPS-induced type 2 cytokines in macrophages. To understand the mechanisms by which LPS induces type 2 cytokine gene expression, macrophages were stimulated with LPS, and the expression of IL-4 and IL-5 genes were examined. LPS, acting through TLR4, activates both type 1 and type 2 cytokine production both in vitro and in vivo by using macrophages from C3H/HeJ or C3H/HeOuJ mice. Although the baseline level of both TNFα and IL-4 protein was very low, TNFα was released rapidly after stimulation (within 4 h); however, IL-4 was released after 48 h LPS stimulation in secreted form. Silencing of myeloid differentiation protein (MyD88) and TRIF-related adaptor molecule (TRAM), using small interfering RNA abolished IL-4 induction induced by LPS whereas silencing of TRAM has no effect on TNFα induction, thereby indicating that LPS-induced TNFα is MyD88-dependent but IL-4 is required both MyD88 and TRAM. These findings suggest a novel function of LPS and the signaling pathways in the induction of IL-4 gene expression. Pathogen-associated molecular patterns (PAMPs) 2The abbreviations used are: PAMPpathogen-associated molecular patternsLPSlipopolysaccharideTLR4Toll-like receptor 4BMDMsbone marrow-derived macrophagesActDactinomycin DCHXcycloheximideMyD88myeloid differentiation proteinTRAMTRIF-related adaptor moleculeTRIFTIR domain-containing adaptor-inducing interferon-γTIRToll/interleukin-1 resistance domainTNFtumor necrosis factorNF-κBnuclear factor κBQRT-PCRquantitative real time-PCRILinterleukinELISAenzyme-linked immunosorbent assayAMhuman alveolar macrophagessiRNAsmall interfering RNA. such as bacterial LPS are powerful activators of the innate immune system. Exposure to LPS induces an inflammatory reaction in the lung, mediated primarily by an array of inflammatory chemokines and cytokines released by blood monocytes and alveolar macrophages. Mammalian Toll-like receptors (TLRs) are key molecules for recognizing microbial PAMPs and transducing the subsequent inflammatory response (1Rock F.L. Hardiman G. Timans J.C. Kastelein R.A. Bazan J.F. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 588-593Crossref PubMed Scopus (1463) Google Scholar). LPS is well known to interact with macrophages via TLR4 receptor resulting in cellular activation and synthesis and release of type 1 proinflammatory cytokines such as IFNγ, IL-2, and TNFα (2Gioannini T.L. Teghanemt A. Zhang D. Coussens N.P. Dockstader W. Ramaswamy S. Weiss J.P. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 4186-4191Crossref PubMed Scopus (302) Google Scholar, 3Pouliot P. Turmel V. Gélinas E. Laviolette M. Bissonnette E.Y. Clin. Exp Allergy. 2005; 35: 804-810Crossref PubMed Scopus (50) Google Scholar). These cytokines can further activate monocytes, neutrophils, and lymphocytes, initiating cellular injury and tissue damage (4Svanborg C. Godaly G. Hedlund M. Curr. Opin. Microbiol. 1999; 2: 99-105Crossref PubMed Scopus (149) Google Scholar, 5Matsukawa A. Yoshinaga M. Inflamm. Res. 1998; 47: S137-S144Crossref PubMed Scopus (36) Google Scholar). pathogen-associated molecular patterns lipopolysaccharide Toll-like receptor 4 bone marrow-derived macrophages actinomycin D cycloheximide myeloid differentiation protein TRIF-related adaptor molecule TIR domain-containing adaptor-inducing interferon-γ Toll/interleukin-1 resistance domain tumor necrosis factor nuclear factor κB quantitative real time-PCR interleukin enzyme-linked immunosorbent assay human alveolar macrophages small interfering RNA. Inhaled LPS signaling through TLR4 has also been shown to be necessary to induce type 2 responses to inhaled antigens in a mouse model of allergic asthma (6Eisenbarth S.C. Piggott D.A. Huleatt J.W. Visintin I. Herrick C.A. Bottomly K. J. Exp. Med. 2002; 196: 1645-1651Crossref PubMed Scopus (1004) Google Scholar). IL-4, the prototypic type 2 cytokine, is a pleiotropic cytokine with regulatory effects on B cell growth, T cell growth, and function, immunoglobulin class switching to IgE during the development of immune responses (7Paul W.E. Blood. 1991; 77: 1859-1870Crossref PubMed Google Scholar). It is also involved in promoting cellular inflammation in the asthmatic lung and contributes to the pathogenesis of allergy and lung remodeling in chronic asthma (8Doucet C. Brouty-Boyé D. Pottin-Clemenceau C. Jasmin C. Canonica G.W. Azzarone B. Int. Immunol. 1998; 10: 1421-1433Crossref PubMed Scopus (171) Google Scholar, 9Moser R. Fehr J. Bruijnzeel P.L. J. Immunol. 1992; 149: 1432-1438PubMed Google Scholar). Different cell types have been reported to produce IL-4 including the well known CD4+ and CD8+ T cells (10Dombrowicz D. Capron M. Curr. Opin. Immunol. 2001; 13: 716-720Crossref PubMed Scopus (96) Google Scholar, 11Wills-Karp M. Annu. Rev. Immunol. 1999; 17: 255-281Crossref PubMed Scopus (962) Google Scholar), basophils (12Min B. Prout M. Hu-Li J. Zhu J. Jankovic D. Morgan E.S. Urban Jr., J.F. Dvorak A.M. Finkelman F.D. LeGros G. Paul W.E. J. Exp. Med. 2004; 200: 507-517Crossref PubMed Scopus (357) Google Scholar), natural killer cells (13Yoshimoto T. Paul W.E. J. Exp. Med. 1994; 179: 1285-1295Crossref PubMed Scopus (805) Google Scholar), mast cells (14Plaut M. Pierce J.H. Watson C.J. Hanley-Hyde J. Nordan R.P. Paul W.E. Nature. 1989; 339: 64-67Crossref PubMed Scopus (1033) Google Scholar), and eosinophils (15Moqbel R. Ying S. Barkans J. Newman T.M. Kimmitt P. Wakelin M. Taborda-Barata L. Meng Q. Corrigan C.J. Durham S.R. Kay A.B. J. Immunol. 1995; 155: 4939-4947PubMed Google Scholar). Pouliot et al. (3Pouliot P. Turmel V. Gélinas E. Laviolette M. Bissonnette E.Y. Clin. Exp Allergy. 2005; 35: 804-810Crossref PubMed Scopus (50) Google Scholar) have shown that human alveolar macrophages (AMs) can produce IL-4 in response to PMA and calcium ionophore A23187, and they suggest that AMs might play a crucial role in the type 1/type 2 balance in the lung. LPS-stimulated production of type 1 cytokines such as TNFα and INFγ has been extensively studied in macrophages; however, LPS-stimulated production of type 2 cytokines by macrophages has not yet been well defined. Because the presence of IL-4 at the site of a developing immune response can skew the ultimate cytokine pattern, alveolar macrophage produced IL-4 may be important in the development of allergic airway disease. Indeed, TLR4-defective mice studied using a standard murine model of allergic airway inflammation had an overall decrease in lung inflammatory responses, a dramatic reduction of eosinophils and lymphocytes, and lower circulating levels of OVA-specific IgE (16Dabbagh K. Dahl M.E. Stepick-Biek P. Lewis D.B. J. Immunol. 2002; 168: 4524-4530Crossref PubMed Scopus (213) Google Scholar). The intracellular events following LPS stimulation of TLR4 depends on different sets of Toll/interleukin-1 resistance (TIR) domain containing adaptor molecules. These adaptors provide a structural platform for the recruitment of downstream effector molecules (17O'Neill L.A. Fitzgerald K.A. Bowie A.G. Trends Immunol. 2003; 24: 286-290Abstract Full Text Full Text PDF PubMed Scopus (419) Google Scholar, 18Vogel S.N. Fitzgerald K.A. Fenton M.J. Mol. Interv. 2003; 3: 466-477Crossref PubMed Scopus (203) Google Scholar). Two distinct responses following engagement of TLR4 with LPS have been described. An early response leading to activation of NF-κB is dependent on MyD88, while a late response utilizes TIR domain-containing adaptor-inducing interferon-γ (TRIF) and TRIF-related adaptor molecule (TRAM) to activate NF-κB (19Pålsson-McDormott E.M. O'Neil L.A. Immunology. 2004; 113: 153-162Crossref PubMed Scopus (978) Google Scholar). While TRIF is common to both TLR3 and TLR4 pathways, TRAM is highly specific for TLR4 (20Fitzgerald K.A. Rowe D.C. Barnes B.J. Caffrey D.R. Visintin A. Latz E. Monks B. Pitha P.M. Golenbock D.T. J. Exp. Med. 2003; 198: 1043-1055Crossref PubMed Scopus (941) Google Scholar). The complex signaling network initiated by the interaction of the adaptor and effector proteins ultimately decides the specific pattern of gene expression that is elicited in response to TLR agonists and the particular type of cytokine that is produced determines the recruitment and activation of other immune cells. Therefore, further clarification of the cellular responses following the activation of TLR is crucial and fundamental to our understanding of immune responses. In this report, we show that LPS can stimulate de novo IL-4 gene expression in murine macrophages, both in vitro and in vivo. Utilizing RNA interference we further showed that the induction of IL-4 is both MyD88- and TRAM-dependent (MyD88-independent), while LPS-induced TNFα is strictly dependent on MyD88. These results indicate that LPS induces IL-4 production by macrophages, and provide a new molecular mechanism controlling the regulation of IL-4 prior to the emergence of a polarized adaptive immune response. The RAW264.7 murine macrophage cell line was from American Type Culture Collection (ATCC) (Manassas, VA) and cultured in DMEM with GlutaMAX-1, HEPES (Invitrogen, Carlsbad, CA) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and penicillin-streptomycin. The MH-S murine alveolar macrophage cell line was a kind gift from Dr. R. G. Worth (University of Toledo, HSC, Toledo, OH). MH-S cells were cultured in RPMI 1640 with l-glutamine (Invitrogen, Carlsbad, CA) sodium bicarbonate (1.5g/liter), glucose (4.5g/liter) HEPES (10 mm), sodium pyruvate (1 mm), 0.05 mm 2-mercaptoethanol, and 10% heat-inactivated FBS. Both RAW264.7 cells and the MH-S cells were cultured in an incubator at 37 °C and 5% CO2. C3H/HeJ (TLR4d), C3H/HeOuJ, and C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME), and all animal experiments were approved by the Institutional Animal Care and Use Committee at The Scripps Research Institute and Medical University of Ohio. Mice were treated intranasally with LPS (0.3 mg/kg) in 50 μl of sterile PBS (control), administered under light anesthesia. Broncho-alveolar lavage (BAL) was performed by cannulating the trachea and performing lavage with 1 ml of sterile PBS. To characterize airway cells, cytocentrifuge slides prepared using BAL fluid were stained with Wright-Giemsa stain and examined by light microscopy. BAL fluid cytokine levels were measured by ELISA using commercially available kits. 8–10-week old mice were euthanized and bone marrow cells obtained from femurs by flushing the bone marrow cavities with complete media (RPMI (Cell-Gro, Kansas City, MO), 10% horse serum (Invitrogen), 0.5% glutamax, 1% penicillin-streptomycin, 0.1% 2-mercaptoethanol, and 30% L929 supernatant (source of M-CSF)). Bone marrow cells were cultured for 4 days in the complete medium in an incubator at 37 °C and 5% CO2. On the fourth day, the medium was changed, and the cells cultured for another 2 days. On the sixth day the cells were detached using a rubber policeman and centrifuged at 1,100 rpm for 5 min at 4 The were and at a of cells ml or on the or RAW264.7 cells were treated with of LPS CA) for the Culture were and RNA or protein were prepared from the cells and were at °C On the day of the supernatant were by the and for secreted IL-4 and by ELISA to the stimulation with LPS, cells were with PBS and treated with μl of mm 5 mm 1% mm 1 mm sodium and of in 50 ml of for min on centrifuged at 4 °C for were and the protein were by assay using the and the μl of was to the of protein and at °C for on for 2 and centrifuged for 1 min at of protein were in and by proteins were a were with specific to IL-4 MyD88 or TRAM CA) by mouse and and by and the CA) system. To an the was mm mm and to and with CA) by and as RNA was using the following in the resulting RNA was by using the to the 1 of RNA was to using CA) following the were prepared by performing in the of real was with using 1 and an City, The was from and gene expression was using the of the gene induction of the gene was using the The containing the the IL-4 was a kind gift of Dr. C.A. J. Immunol. Google Scholar). The MyD88 was as S. J. Immunol. 2002; PubMed Scopus Google Scholar). RAW264.7 cells were at a of cells well in tissue and h they were with of and 0.05 using to the the cells were stimulated with LPS for or stimulation the was measured by the to the and the experiments with MyD88, the RAW264.7 cells were with and and or and and and stimulated with LPS for small interfering RNA were purchased from and cells were with 2 of the in RAW264.7 was by with of the and the effect using microscopy. To the of gene the cell of the cells was used for as and using specific for MyD88 and TRAM. The were with silencing and was used as and the protein were also to to the silencing RAW264.7 cells were or with the h prior to the of the of and 0.05 of in the tissue cells were stimulated with LPS for different following which was of MH-S cells and the we used cell line and mouse macrophage following the was performed with of 0.05 were of bacterial LPS induced in vivo type 2 cytokine production in C3H/HeOuJ which are to Mice were treated with LPS (0.3 mg/kg) administered intranasally in 50 μl of sterile or lavage (BAL) fluid was for cells as well as levels of type 1 cytokine and type 2 cytokines and and Mice to LPS had cells in lavage fluid the mice to was also a dramatic and in the of type 2 cytokines in mice LPS and that bacterial LPS can induce a type 2 response in the murine model of lung bacterial LPS also induced type 2 cytokine gene expression in macrophages. RAW264.7 murine macrophages, MH-S murine alveolar macrophages or from C57BL/6 mice were stimulated with LPS (10 for Both RAW264.7 and MH-S macrophages are from mice. Because mice are to a Th2 we also to macrophages from C57BL/6 mice. LPS induced IL-4 and TNFα expression in a with the The were for all macrophage cell types in that was a different response IL-4 and TNFα induced by TNFα at 4 h to baseline In was little in IL-4 levels and levels to at 48 the induction of cytokine gene not with protein and we also cytokine the supernatant of LPS-stimulated RAW264.7 cells. to the gene expression we a but in TNFα with a and in IL-4 and our suggest that LPS induces a response in macrophages. response of a but stimulation of TNFα, by a and stimulation of The that TLR4 the LPS receptor and the effect of stimulation with LPS was a in our understanding of cytokine gene has that LPS may be with other and that the of LPS stimulation may signaling through other Therefore, we the role of TLR4 in LPS-induced macrophage IL-4 production using a TLR4 that of LPS to of RAW264.7 cells with the the LPS-induced IL-4 release in macrophages indicating that LPS-induced IL-4 release in macrophages LPS to To further this we the responses in from mice to the responses in TLR4-defective mice were stimulated with LPS for different and 48 and IL-4 measured by quantitative of TLR4-defective with LPS to induce IL-4 In LPS-induced IL-4 in the of with LPS in TLR4-defective and mice mice the in cells and IL-4 protein In TLR4-defective mice to show an in cell or IL-4 protein These in vivo results are with the in vitro results and that bacterial LPS-induced IL-4 production in macrophages and the airway are that bacterial LPS-induced type 2 cytokine production in a LPS-induced TNFα synthesis has been shown to be mediated through the molecule MyD88 (19Pålsson-McDormott E.M. O'Neil L.A. Immunology. 2004; 113: 153-162Crossref PubMed Scopus (978) Google Scholar). LPS-induced IL-4 production was also mediated through MyD88. cells were with a of MyD88 as well as a IL-4 that the MyD88 LPS-induced IL-4 that the signaling may to LPS-induced IL-4 To we a small interfering RNA to MyD88 or TRAM specific for RAW264.7 cells were with MyD88, or both MyD88 and TRAM. While MyD88 and TRAM IL-4 MyD88 and TRAM in complete of with we also showed that silencing MyD88 or TRAM IL-4 protein but that silencing of both MyD88 and TRAM to complete of IL-4 release in the RAW264.7 cells also a to MyD88 and TRAM in the MH-S alveolar macrophage cell line as well as in from C57BL/6 mice using the These that MyD88-dependent and pathways are both involved in LPS-induced type 2 cytokine IL-4 protein release both MyD88 and TRAM pathways, while LPS-induced protein release is MyD88-dependent and RAW264.7 cells were with MyD88 or TRAM or both day the cells were stimulated with LPS for the The were and were to IL-4 and levels by following the The was with are as was using the and a 0.05 was showed that TNFα and IL-4 production in macrophages are both but that the type 1 cytokine response is early while the type 2 cytokine response is To this we LPS-stimulated IL-4 and TNFα responses different TLR4 adaptor proteins in RAW264.7 cells. that LPS-induced IL-4 production both MyD88-dependent and pathways LPS-induced TNFα however, was dependent on MyD88 and was of TRAM T. T. K. S. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar). our indicate that the MyD88-dependent is necessary and for LPS-stimulated TNFα production in macrophages, but that LPS-stimulated IL-4 production both MyD88-dependent and or LPS is a key of the innate immune to an array of cytokines and chemokines that inflammatory cells to the involved tissue as well as immune and inflammatory responses (4Svanborg C. Godaly G. Hedlund M. Curr. Opin. Microbiol. 1999; 2: 99-105Crossref PubMed Scopus (149) Google Scholar, A. Yoshinaga M. Inflamm. Res. 1998; 47: S137-S144Crossref PubMed Google Scholar). While LPS is an of the innate immune response to to inhaled LPS also as a of presence in J. R. J. 1989; PubMed Scopus Google Scholar, R. B. J. J. R. Rev. 1992; PubMed Scopus Google Scholar, A.M. M. J. J. P. R. J. Care Med. PubMed Scopus Google Scholar). In we and have that LPS activation of NF-κB and production of type 1 cytokine gene expression in macrophages M. S. J. 2003; PubMed Scopus Google Scholar, A. E. A. C. R. S. D. J. Immunol. 2004; PubMed Scopus Google Scholar, R. 2003; PubMed Scopus Google Scholar). The of LPS to stimulate type 2 cytokine gene expression from macrophages is not as well described. little is known the cellular signaling pathways transducing The that LPS induces type 2 cytokine production in vitro and in vivo. results also that the signaling leading to LPS-induced IL-4 TLR4, MyD88, and TRAM. These results for the that LPS-stimulated type 1 cytokine production is whereas LPS-stimulated IL-4 production both MyD88-dependent and C3H/HeOuJ and C3H/HeJ macrophage cell as well as macrophages, we showed that LPS stimulated IL-4 synthesis in a both in vitro and in vivo. Although a has shown that of LPS type 2 and type 1 (6Eisenbarth S.C. Piggott D.A. Huleatt J.W. Visintin I. Herrick C.A. Bottomly K. J. Exp. Med. 2002; 196: 1645-1651Crossref PubMed Scopus (1004) Google Scholar), our showed that LPS induces both type 1 and type 2 cytokines in a with a TNFα response induced early whereas IL-4 had a but in the of the cytokine response to with of downstream TLR4 signaling LPS-stimulated TNFα production the MyD88-dependent while LPS-stimulated IL-4 production involved both MyD88-dependent and play in response to injury and are to the of Gram-negative LPS, signaling through of TLR4 on cells triggers of proinflammatory cytokines, and the for the activation of T cells Curr. Opin. Immunol. 2002; PubMed Scopus Google Scholar, D.R. Curr. Opin. Immunol. 2004; PubMed Scopus Google Scholar). is that TLR4 signaling has the to the adaptive immune thereby the of and microbial Zhu J. Paul W.E. J. Exp. Med. 2005; PubMed Scopus Google Scholar). The type 1 proinflammatory cytokine response from LPS stimulation of macrophages has been extensively that LPS may also stimulate type 2 cytokines from macrophages C. A. T. G. P. J. Mol. 17: PubMed Scopus Google Scholar, A. Full Text Full Text PDF PubMed Scopus Google however the of this response and the signaling events recent that to LPS the development and of various inflammatory including to type 2 responses (6Eisenbarth S.C. Piggott D.A. Huleatt J.W. Visintin I. Herrick C.A. Bottomly K. J. Exp. Med. 2002; 196: 1645-1651Crossref PubMed Scopus (1004) Google Scholar). The of LPS to asthmatic airway inflammation suggest that to LPS prior to allergic may subsequent and development of asthma Immunol. 1995; PubMed Scopus Google Scholar, Clin. Exp. Allergy. PubMed Scopus Google however, to LPS in asthmatic to airway inflammation and R. B. J. J. R. Rev. 1992; PubMed Scopus Google Scholar) and of has been shown to IgE responses in mice D.B. J. Clin. Immunol. Full Text Full Text PDF PubMed Scopus Google Scholar). studies have shown that asthmatic airway inflammation and at lower of inhaled LPS J. R. J. 1989; PubMed Scopus Google Scholar, R. B. J. J. R. Rev. 1992; PubMed Scopus Google Scholar), and this to LPS is further following J. J. L. R. R. J. Care Med. PubMed Scopus Google Scholar). asthma has been to the of LPS in J. J. L. R. R. J. Care Med. PubMed Scopus Google Scholar). suggest that stimulation of macrophages with LPS can induce but IL-4 in to prior indicating that TLR signaling is not important for the induction of type 2 responses M. K. S. R. Immunol. 2001; 2: PubMed Scopus Google Scholar). results suggest that LPS has a effect on macrophages, an type 1 cytokine response that is by a type 2 cytokine response. that are to to LPS, our results suggest that the effect of LPS on airway macrophages play a role in in vivo adaptive immune responses, including the development of type 2 cytokine responses. In we have shown that LPS, acting through TLR4, activates both type 1 and type 2 cytokine production in vitro and in vivo. have also shown that LPS-induced TNFα production in macrophages is and while LPS-induced IL-4 production in macrophages is and both MyD88 and TRAM signaling pathways These findings provide the that a of LPS both type 1 and type 2 cytokine responses through distinct patterns and signaling
30
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Taro Kawai, Osamu Adachi, Tomohiko Ogawa et al. · Immunity · 1999 · 2.1K citations · Full text
Toll-like receptors control activation of adaptive immune responses
Markus Schnare, Gregory M. Barton, Agnieszka Czopik Holt et al. · Nature Immunology · 2001 · 1.4K citations
Toll-Like Receptor Signaling Pathways
Gregory M. Barton, Ruslan Medzhitov · Science · 2003 · 1.3K citations